Article
Mesenchymal stem cells maintain their defining stem cell characteristics after treatment with cisplatin.
Scientific reports - 25 Jan 2016
Nicolay Nils H, Lopez Perez Ramon, Rühle Alexander, Trinh Thuy, Sisombath Sonevisay, Weber Klaus-Josef, Ho Anthony D, Debus Jürgen, Saffrich Rainer, Huber Peter E
Abstract excerpt
Mesenchymal stem cells (MSCs) aid the regeneration of tissues damaged by treatment with cisplatin. However, the effects of this cytotoxic drug on the stem cells have been largely unknown. Here we demonstrate that human bone marrow-derived MSCs are relatively resistant to cisplatin treatment and show resistance levels comparable to these of differentiated fibroblasts. Cisplatin did not affect cellular morphology,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
